Rare diseases are not actually that rare. Collectively they affect 500 million people around the world. Some, such as Huntington’s disease and sickle cell disease, affect many thousands, others only ...
The availability of more affordable genetic testing allows us to screen newborns for more treatable inherited and congenital conditions.
A version of this Priestley Medal address will be presented at the American Chemical Society Spring 2026 meeting ...
Sickle cell disease—the subject of a new Seminar in The Lancet—is one of the most prevalent and fastest-growing genetic disorders worldwide. Although its true prevalence is difficult to determine ...
A better treatment for sickle cell disease, which strikes mainly people of color, is transforming medicine in Philadelphia, making this Black History Month especially meaningful for one local family.
On her best days, Tatyana Thompson’s pain was at a level five. Some days, it would stay that way, a persistent throb in her joints, her hands, her back. On other days, if she was dehydrated or was hit ...
Morning Overview on MSN
Gene editing advances raise real prospects for future DNA upgrades
The U.S. Food and Drug Administration approved the first cell-based gene therapies for sickle cell disease, including the ...
Advances in sickle cell therapies, including gene editing, offer hope—but racial disparities, cost, and access barriers remain major challenges. Racial and ethnic disparities in health care persist in ...
PHILADELPHIA (KYW) -- A better treatment for sickle cell disease, which strikes mainly people of color, is transforming medicine in Philadelphia, making this Black History Month especially meaningful ...
Add Yahoo as a preferred source to see more of our stories on Google. A Michigan man is the first patient in the state, outside of clinical trials, to receive a new gene therapy for hemophilia A at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results